Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

UFS trains Kovsies to become great in world terms – Prof Jonathan Jansen

2016-01-19

First-year students from the University of the Free State (UFS) recently attended the welcoming ceremony at the Red Square of the Bloemfontein Campus.
Photo: Johan Roux

The University of the Free State (UFS) does not train Kovsies to become great in Bloemfontein or even South Africa. The UFS trains them to become great in the world.

With these words, Prof Jonathan Jansen welcomed the first-year class of 2016 to the “home of Wayde van Niekerk, Rolene Strauss, and the 2015 Varsity Cup rugby champions”.

Prof Jansen, Vice-Chancellor and Rector of the UFS, welcomed the newcomers to the start of the “best time of their lives” on 15 January 2016 at the Red Square of the Bloemfontein Campus. First-years and their parents attended the annual welcoming ceremony.

Prof Jansen congratulated the students on choosing the UFS, and on being part of the elite group that was selected to study at the university.

The UFS received 25 142 applications from newcomers, he said, although there are only about 8 000 places. In 2015, there were roughly 17 500 applications.

He said it was also the most diverse group of applications the UFS had ever received.

Access to education

According to Prof Jansen, the UFS is committed to helping poor students gain access to education, no matter what their background or the colour of their skin.

Lindokuhle Ntuli, the UFS Student Representative Council (SRC) President, said higher education should be more accessible. He said South Africa has allowed education to become commercialised.

“The sooner we as a country realise education isn’t an expense, but rather an investment, the better,” he said.

UFS campaigns

Prof Jansen thanked the UFS SRC for the Right to Learn (R2L) campaign. Launched by the SRC on 30 October 2015, this campaign has already raised R1.2 million to help academically-deserving underprivileged students to study.

“I have launched a campaign myself to raise R100 million between now and September. About 50% of my time will go into this,” Prof Jansen said.

“I will work tirelessly with Lindokuhle and the SRC to raise money.”

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept